External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

Equity Bottom-Up

<ul><li>CVS is experiencing declining performance in its Pharmacy &amp; Consumer Wellness operations</li><li>Author believes CVS's situation is similar to using bad grapes to make wine and that the segment is essentially terminal</li><li>Author suggests potential 30%+ downside for CVS and recommends pair trades like going long on CI and short on CVS, as well as noting activist investor Glenview Capital's 1% stake in CVS</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

CVS is experiencing declining performance in its Pharmacy &amp; Consumer Wellness operationsAuthor believes CVS's situation is similar to using bad grapes to make wine and that the segment is essentially terminalAuthor suggests potential 30%+ downside for CVS and recommends pair trades like going long on CI and short on CVS, as well as noting activist investor Glenview Capital's 1% stake in CVSThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Cvs Health Corp (CVS) - Thursday, Oct 3, 2024

Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

<ul><li>CVS Health's recent third-quarter 2024 earnings report presents a multifaceted view of the company's performance and strategic direction.</li><li>The company's revenue reached approximately $95.4 billion, marking a 6% increase from the previous year.</li><li>However, the adjusted earnings per share (EPS) of $1.09 indicate challenges, particularly within the Health Care Benefits (HCB) segment.</li></ul>

CVS Health's recent third-quarter 2024 earnings report presents a multifaceted view of the company's performance and strategic direction.The company's revenue reached approximately $95.4 billion, marking a 6% increase from the previous year.However, the adjusted earnings per share (EPS) of $1.09 indicate challenges, particularly within the Health Care Benefits (HCB) segment.

CVS Health Corporation: Expansion & Optimization of Health Services As A Critical Factor Driving Growth! - Major Drivers

<ul><li>In the second quarter of 2024, CVS Health reported mixed financial results, underscored by significant achievements and notable challenges.</li><li>The company delivered an adjusted earnings per share of $1.83 and saw revenues exceeding $91 billion, with an operating cash flow of $8 billion for the first half of the year.</li><li>This was supported by a strong performance in the Health Services and Pharmacy & Consumer Wellness segments.</li></ul>

In the second quarter of 2024, CVS Health reported mixed financial results, underscored by significant achievements and notable challenges.The company delivered an adjusted earnings per share of $1.83 and saw revenues exceeding $91 billion, with an operating cash flow of $8 billion for the first half of the year.This was supported by a strong performance in the Health Services and Pharmacy & Consumer Wellness segments.

CVS Health Corporation: Strategic Leverage in Pharmacy Benefit Management (PBM) and Insurance Operations!  - Major Drivers

<ul><li>In the Q1 2024 earnings, CVS Health is experiencing both positive and negative impacts on its business structure.</li><li>The company reported lower-than-expected earnings per share of $1.31 due to significant utilization pressures in the Medicare Advantage, largely impacting its Health Care Benefits segment.</li><li>Due to these results and revised expectations for the rest of 2024, CVS has lowered full-year guidance for adjusted EPS to at least $7.</li></ul>

In the Q1 2024 earnings, CVS Health is experiencing both positive and negative impacts on its business structure.The company reported lower-than-expected earnings per share of $1.31 due to significant utilization pressures in the Medicare Advantage, largely impacting its Health Care Benefits segment.Due to these results and revised expectations for the rest of 2024, CVS has lowered full-year guidance for adjusted EPS to at least $7.

CVS Health Corporation: Will The  Increasing Margin in Medicare Advantage Last? - Major Drivers

<ul><li>Analyzing the latest earnings call transcript of CVS Health, it becomes evident that the company has managed to successfully navigate through a challenging environment and deliver on its financial commitments, underscoring the strength of its diversified business model.</li><li>Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.</li><li>In this report, we have carried out a fundamental analysis of the historical financial statements of the company.</li></ul>

Analyzing the latest earnings call transcript of CVS Health, it becomes evident that the company has managed to successfully navigate through a challenging environment and deliver on its financial commitments, underscoring the strength of its diversified business model.Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.In this report, we have carried out a fundamental analysis of the historical financial statements of the company.

CVS Health Corporation: Integration Of Acquired Businesses

United States

CVS Health Corporation is an integrated pharmacy health care provider. The Company's offerings include pharmacy benefit management services; mail order, retail and specialty pharmacy; disease management programs; and retail clinics. The company operates drugstores throughout the U.S., the District of Columbia, and Puerto Rico.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Cvs Health Corp (CVS US)

Cvs Health Corp (CVS) - Thursday, Oct 3, 2024

Author suggests potential 30%+ downside for CVS and recommends pair trades like going long on CI and short on CVS, as well as noting activist...

Value Investors Club

CVS Health Corporation: Expansion & Optimization of Health Services As A Critical Factor Driving Growth! - Major Drivers

CVS Health's recent third-quarter 2024 earnings report presents a multifaceted view of the company's performance and strategic direction. The...

Baptista Research

CVS Health Corporation: Strategic Leverage in Pharmacy Benefit Management (PBM) and Insurance Operations! - Major Drivers

In the second quarter of 2024, CVS Health reported mixed financial results, underscored by significant achievements and notable challenges. The...

Baptista Research

CVS Health Corporation: Will The Increasing Margin in Medicare Advantage Last? - Major Drivers

In the Q1 2024 earnings, CVS Health is experiencing both positive and negative impacts on its business structure. The company reported...

Baptista Research

CVS Health Corporation: Integration Of Acquired Businesses

Analyzing the latest earnings call transcript of CVS Health, it becomes evident that the company has managed to successfully navigate through a...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)